Asthma & ABPA Pre-Screening Study

• Research type

  Research Study

• Full title

  A Prescreening Study to Diagnose Allergic Bronchopulmonary Aspergillosis in Selected Patients with Asthma

• IRAS ID

  329975

• Contact name

  Rory Taylor

• Contact email

  rory.taylor@cpsresearch.co.uk

• Sponsor organisation

  Pulmatrix Inc

• Clinicaltrials.gov Identifier

  NCT05903612

• Duration of Study in the UK

  0 years, 7 months, 5 days

• Research summary

  This prescreening study is to diagnose Allergic Bronchpulmonary Aspergillosis (ABPA)in selected patients with asthma. In turn, this will increase the potential number of eligible participants for an ongoing study (IRAS 1006803) investigating an inhaler for ABPA sufferers.

  Participants involvement in the study will only last for between 2-4 weeks.

  The study's aiming to recruit patients over the age of 18 who have a diagnosis of asthma and have had at least one exacerbation that required treatment in the last 10 months.

• REC name

  Wales REC 7

• REC reference

  23/WA/0277

• Date of REC Opinion

  21 Dec 2023

• REC opinion

  Further Information Favourable Opinion